Naselin, one of the leading nasal decongestant brands by Cipla has bagged “Silver” at the Effie APAC Awards.

Cipla Health said that Naselin becomes Cipla’s first ever brand to win a marketing award in the Asian Pacific region, which is one of the industry's most distinguished accolades for marketing effectiveness.

APAC Effie Awards are globally recognized as the gold standard for agencies and clients alike.

Naselin has been recognized out of the 29 Indian brands and from the total of 107 brands across the Asia Pacific region which is a gratifying moment for the brand.

The award winning TVC ‘Shubhratri, Prajapati - The Guard” campaign underlines the significance of choosing the appropriate product by narrating an anecdote of a watchman who has sleep deprivation triggered by nasal congestion and struggles to get a good night’s sleep.

Shivam Puri, CEO – Cipla Health says, “I am truly pleased and humbled by this recognition being bestowed on Cipla Health. These awards are a reflection of our purposeful strides and our relentless commitment to address the unmet needs of our consumers. Driven by deep consumer insights and marketing expertise, Cipla Health has always strived to enhance the lives of our consumers with the most innovative and effective solutions.”

Related Article :-

Centre approves nasal vaccine for COVID19

Centre asks people to mask up, get booster dose amid a surge of COVID cases in China

China set to open borders, drop quarantine mandate amid rising cases

India’s first nasal COVID vaccine dose to cost Rs 800

Remain prepared for any COVID19 surge: Center to states

PM Modi to chair meeting on COVID19

WHO DG urges China to share more information on COVID surge

No need to panic, adopt COVID appropriate behavior: IMA

Shanghai authorities ask schools to go into online mode amid surging COVID cases

Refrain from making speculations: Mandaviya to doctors on COVID-19